Activation of downstream signaling by the gp130 family: Upon binding to gp130 and their cytokine-specific receptor on tumor cells, the gp130 ligands are known to activate the JAK/STAT, MAPK/MEK/ERK, and PI3K/AKT signaling pathways [20,21,22,23]. Here, SOAT1 is linked to neoplasm.